YAP1 and neoplasm: For instance, pan-TEAD inhibitors such as GNE-7883 block the interaction between YAP/TAZ and TEAD, thereby significantly inhibiting tumor growth and reversing resistance to KRAS inhibitors (Thrash and Pendergast, 2023; Thompson, 2020).